Cloud Defense Logo

Products

Solutions

Company

Book A Live Demo

CVE-2022-47376 Explained : Impact and Mitigation

Learn about CVE-2022-47376, a vulnerability in Alaris Infusion Central software versions 1.1 to 1.3.2. Discover the impact, technical details, and mitigation steps.

This article provides an overview of CVE-2022-47376, a vulnerability found in the Alaris Infusion Central software. Learn about the impact, technical details, and how to mitigate this security issue.

Understanding CVE-2022-47376

CVE-2022-47376 is a security vulnerability identified in the Alaris Infusion Central software, versions 1.1 to 1.3.2. The presence of a recoverable password after installation poses a risk to system security.

What is CVE-2022-47376?

The Alaris Infusion Central software, in versions 1.1 to 1.3.2, may contain a recoverable password post-installation. While patient health data is not stored in the database, some site installations may choose to store personal data, making it crucial to address this vulnerability.

The Impact of CVE-2022-47376

The vulnerability exposes a recoverable password in the Alaris Infusion Central software, potentially leading to unauthorized access and data exposure. Although patient health data is not at risk, stored personal data could be compromised.

Technical Details of CVE-2022-47376

The following section outlines key technical details of the CVE-2022-47376 vulnerability.

Vulnerability Description

The issue arises from the presence of a recoverable password in versions 1.1 to 1.3.2 of the Alaris Infusion Central software, allowing unauthorized access and data exposure.

Affected Systems and Versions

        Vendor: n/a
        Product: Alaris Infusion Central
        Affected Versions: 1.1 to 1.3.2

Exploitation Mechanism

The vulnerability can be exploited by attackers with access to the recoverable password to gain unauthorized entry into the Alaris Infusion Central software.

Mitigation and Prevention

Protect your systems from CVE-2022-47376 with the following mitigation strategies and best practices.

Immediate Steps to Take

        Ensure recovery of the password in the Alaris Infusion Central software to prevent unauthorized access.
        Implement access controls and encryption measures to safeguard stored personal data.

Long-Term Security Practices

        Regularly review and update security configurations to address vulnerabilities promptly.
        Conduct security audits and assessments to identify and mitigate potential risks.

Patching and Updates

Stay informed about security updates and patches released by the vendor to address the recoverable password vulnerability in the Alaris Infusion Central software.

Popular CVEs

CVE Id

Published Date

Is your System Free of Underlying Vulnerabilities?
Find Out Now